Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney Impairment
Clinical trial NCT02923947 · COMPLETED
Trial details
- NCT number
- NCT02923947
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-04
- Primary completion
- 2018-09-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.